• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜(II)离子影响 20S 蛋白酶体的门控动力学:一项分子和细胞研究。

Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study.

机构信息

Istituto di Biostrutture e Bioimmagini - CNR Sede di Catania, Via P. Gaifami, 9- 95126 Catania, Italy.

Fondazione RiMed, Via Bandiera 11, 90133, Palermo, Italy.

出版信息

Sci Rep. 2016 Sep 16;6:33444. doi: 10.1038/srep33444.

DOI:10.1038/srep33444
PMID:27633879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5025780/
Abstract

Due to their altered metabolism cancer cells are more sensitive to proteasome inhibition or changes of copper levels than normal cells. Thus, the development of copper complexes endowed with proteasome inhibition features has emerged as a promising anticancer strategy. However, limited information is available about the exact mechanism by which copper inhibits proteasome. Here we show that Cu(II) ions simultaneously inhibit the three peptidase activities of isolated 20S proteasomes with potencies (IC50) in the micromolar range. Cu(II) ions, in cell-free conditions, neither catalyze red-ox reactions nor disrupt the assembly of the 20S proteasome but, rather, promote conformational changes associated to impaired channel gating. Notably, HeLa cells grown in a Cu(II)-supplemented medium exhibit decreased proteasome activity. This effect, however, was attenuated in the presence of an antioxidant. Our results suggest that if, on one hand, Cu(II)-inhibited 20S activities may be associated to conformational changes that favor the closed state of the core particle, on the other hand the complex effect induced by Cu(II) ions in cancer cells is the result of several concurring events including ROS-mediated proteasome flooding, and disassembly of the 26S proteasome into its 20S and 19S components.

摘要

由于其代谢改变,癌细胞比正常细胞对蛋白酶体抑制或铜水平变化更为敏感。因此,开发具有蛋白酶体抑制特性的铜配合物已成为一种很有前途的抗癌策略。然而,关于铜抑制蛋白酶体的确切机制的信息有限。在这里,我们表明 Cu(II) 离子同时以微摩尔范围内的效力(IC50)抑制分离的 20S 蛋白酶体的三种肽酶活性。Cu(II) 离子在无细胞条件下既不催化氧化还原反应,也不破坏 20S 蛋白酶体的组装,而是促进与通道门控受损相关的构象变化。值得注意的是,在补充 Cu(II) 的培养基中生长的 HeLa 细胞表现出降低的蛋白酶体活性。然而,在存在抗氧化剂的情况下,这种效应会减弱。我们的结果表明,如果一方面 Cu(II) 抑制的 20S 活性可能与有利于核心颗粒关闭状态的构象变化有关,另一方面 Cu(II) 离子在癌细胞中引起的复杂效应是包括 ROS 介导的蛋白酶体泛滥在内的多种并发事件的结果,以及 26S 蛋白酶体分解为 20S 和 19S 组件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/c4b81e1d1920/srep33444-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/503ebe27ee05/srep33444-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/da2ef6c52b6a/srep33444-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/55b3bb6ae51a/srep33444-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/d227e10759e5/srep33444-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/76b37a8b8e7d/srep33444-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/c4b81e1d1920/srep33444-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/503ebe27ee05/srep33444-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/da2ef6c52b6a/srep33444-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/55b3bb6ae51a/srep33444-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/d227e10759e5/srep33444-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/76b37a8b8e7d/srep33444-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75cd/5025780/c4b81e1d1920/srep33444-f6.jpg

相似文献

1
Copper(II) ions affect the gating dynamics of the 20S proteasome: a molecular and in cell study.铜(II)离子影响 20S 蛋白酶体的门控动力学:一项分子和细胞研究。
Sci Rep. 2016 Sep 16;6:33444. doi: 10.1038/srep33444.
2
Molecular study on copper-mediated tumor proteasome inhibition and cell death.铜介导的肿瘤蛋白酶体抑制与细胞死亡的分子研究。
Int J Oncol. 2010 Jul;37(1):81-87. doi: 10.3892/ijo_00000655.
3
Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.选择性抗癌铜(II)混合配体配合物:靶向活性氧和蛋白酶体。
Metallomics. 2014 Apr;6(4):892-906. doi: 10.1039/c3mt00276d.
4
A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts.二乙二硫代氨基甲酸盐和一价铜构成的双核配合物在胰腺癌培养物和异种移植物中作为蛋白酶体活性抑制剂。
Toxicol Appl Pharmacol. 2013 Dec 15;273(3):477-83. doi: 10.1016/j.taap.2013.09.009. Epub 2013 Sep 20.
5
Ni(II), Cu(II), and Zn(II) diethyldithiocarbamate complexes show various activities against the proteasome in breast cancer cells.二乙基二硫代氨基甲酸盐镍(II)、铜(II)和锌(II)配合物对乳腺癌细胞中的蛋白酶体表现出多种活性。
J Med Chem. 2008 Oct 23;51(20):6256-8. doi: 10.1021/jm8007807. Epub 2008 Sep 25.
6
Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.扁柏酚铜配合物抑制蛋白酶体去泛素化并诱导人癌细胞发生类副凋亡样细胞死亡。
Eur J Pharmacol. 2017 Nov 15;815:147-155. doi: 10.1016/j.ejphar.2017.09.003. Epub 2017 Sep 5.
7
Schiff base Cu(II) complexes as inhibitors of proteasome in human cancer cells.席夫碱铜(II)配合物作为人类癌细胞中蛋白酶体的抑制剂
Bratisl Lek Listy. 2019;120(9):646-649. doi: 10.4149/BLL_2019_107.
8
ECPAS/Ecm29-mediated 26S proteasome disassembly is an adaptive response to glucose starvation.ECPAS/Ecm29 介导的 26S 蛋白酶体解体是对葡萄糖饥饿的适应性反应。
Cell Rep. 2023 Jul 25;42(7):112701. doi: 10.1016/j.celrep.2023.112701. Epub 2023 Jun 27.
9
Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells.二乙基二硫代氨基甲酸盐与铜的复合物:在癌细胞中的作用机制。
Mini Rev Med Chem. 2012 Oct;12(12):1184-92. doi: 10.2174/138955712802762068.
10
Redox regulation of the proteasome via S-glutathionylation.通过 S-谷胱甘肽化对蛋白酶体进行氧化还原调节。
Redox Biol. 2013 Dec 14;2:44-51. doi: 10.1016/j.redox.2013.12.003.

引用本文的文献

1
Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.铜死亡、铁死亡和多细胞凋亡在肿瘤免疫微环境重塑和免疫治疗中的作用:罪魁祸首还是新希望?
Mol Cancer. 2024 Nov 15;23(1):255. doi: 10.1186/s12943-024-02130-8.
2
L-tryptophan and copper interactions linked to reduced colibactin genotoxicity in .色氨酸与铜相互作用与降低大肠杆菌素的遗传毒性有关。
mSystems. 2024 Oct 22;9(10):e0099224. doi: 10.1128/msystems.00992-24. Epub 2024 Sep 12.
3
Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives.

本文引用的文献

1
Cationic porphyrins are tunable gatekeepers of the 20S proteasome.阳离子卟啉是20S蛋白酶体的可调守门人。
Chem Sci. 2016 Feb 1;7(2):1286-1297. doi: 10.1039/c5sc03312h. Epub 2015 Nov 9.
2
Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic Cancer.被诊断为胰腺癌患者的血清硒和铜浓度
Cancer Res Treat. 2016 Jul;48(3):1056-64. doi: 10.4143/crt.2015.282. Epub 2015 Dec 28.
3
Regulating the 20S proteasome ubiquitin-independent degradation pathway.调控20S蛋白酶体非泛素依赖性降解途径。
针对癌症治疗的铜死亡:机制见解与临床展望。
J Hematol Oncol. 2024 Aug 16;17(1):68. doi: 10.1186/s13045-024-01589-8.
4
Exploring the Role of Ubiquitin-Proteasome System in the Pathogenesis of Parkinson's Disease.探索泛素-蛋白酶体系统在帕金森病发病机制中的作用。
Pharmaceuticals (Basel). 2024 Jun 14;17(6):782. doi: 10.3390/ph17060782.
5
Targeting cuproplasia and cuproptosis in cancer.靶向癌症中的铜稳态和铜死亡。
Nat Rev Clin Oncol. 2024 May;21(5):370-388. doi: 10.1038/s41571-024-00876-0. Epub 2024 Mar 14.
6
Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells.蛋白酶体抑制剂通过诱导骨髓瘤细胞发生免疫原性细胞死亡发挥免疫调节作用。
Pharmaceuticals (Basel). 2023 Sep 27;16(10):1367. doi: 10.3390/ph16101367.
7
The Tao of Copper Metabolism: From Physiology to Pathology.铜代谢之道:从生理到病理
Curr Med Chem. 2024;31(35):5805-5817. doi: 10.2174/0929867331666230915162405.
8
Neurodegenerative Proteinopathies Induced by Environmental Pollutants: Heat Shock Proteins and Proteasome as Promising Therapeutic Tools.环境污染物诱导的神经退行性蛋白质病:热休克蛋白和蛋白酶体作为有前景的治疗工具
Pharmaceutics. 2023 Jul 30;15(8):2048. doi: 10.3390/pharmaceutics15082048.
9
Construction of a Cuproptosis-Related Gene Signature for Predicting Prognosis in Gastric Cancer.构建铜死亡相关基因签名预测胃癌预后。
Biochem Genet. 2024 Feb;62(1):40-58. doi: 10.1007/s10528-023-10406-9. Epub 2023 May 27.
10
Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.当前鼻咽癌的治疗方法和新视角:靶向蛋白酶体失调作为鼻咽癌分子标志物的作用。
J Exp Clin Cancer Res. 2021 Jun 21;40(1):202. doi: 10.1186/s13046-021-02010-9.
Biomolecules. 2014 Sep 23;4(3):862-84. doi: 10.3390/biom4030862.
4
Interactions of the natural product kendomycin and the 20S proteasome.天然产物肯德霉素与 20S 蛋白酶体的相互作用。
J Mol Biol. 2014 Sep 9;426(18):3108-3117. doi: 10.1016/j.jmb.2014.06.019. Epub 2014 Jul 16.
5
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases.一种新型蛋白酶体抑制剂通过靶向19S蛋白酶体去泛素化酶和20S蛋白水解肽酶来抑制肿瘤生长。
Sci Rep. 2014 Jun 10;4:5240. doi: 10.1038/srep05240.
6
Redox regulation of the proteasome via S-glutathionylation.通过 S-谷胱甘肽化对蛋白酶体进行氧化还原调节。
Redox Biol. 2013 Dec 14;2:44-51. doi: 10.1016/j.redox.2013.12.003.
7
Advances in copper complexes as anticancer agents.铜配合物作为抗癌剂的研究进展。
Chem Rev. 2014 Jan 8;114(1):815-62. doi: 10.1021/cr400135x. Epub 2013 Oct 8.
8
Inorganic stressors of ubiquitin.泛素的无机应激物。
Inorg Chem. 2013 Aug 19;52(16):9567-73. doi: 10.1021/ic401276x. Epub 2013 Jul 26.
9
Zinc and copper levels in bladder cancer: a systematic review and meta-analysis.膀胱癌中锌和铜的水平:系统评价和荟萃分析。
Biol Trace Elem Res. 2013 Jun;153(1-3):5-10. doi: 10.1007/s12011-013-9682-z. Epub 2013 May 3.
10
Cationic porphyrins are reversible proteasome inhibitors.阳离子卟啉是可逆的蛋白酶体抑制剂。
J Am Chem Soc. 2012 Jun 27;134(25):10451-7. doi: 10.1021/ja300781u. Epub 2012 Jun 6.